The Role of the Immune and Inflammatory Systems in Hypertension

NCT04015635 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2021-05-14

No results posted yet for this study

Summary

To define the cytokine and cellular immune signature of primary hypertension. Cross sectional clinical/laboratory study.

Conditions

Interventions

OTHER

None involved

NO intervention

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-05-07
Primary Completion
2021-09-01
Completion
2021-09-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04015635 on ClinicalTrials.gov